Clinical sequelae and symptoms for a considerable number of COVID-19 patients can linger
for months beyond the acute stage of SARS-CoV-2 infection,“long COVID”. Among the long …

The therapeutic potential of melatonin as a chronobiotic cytoprotective agent to counteract
the consequences of COVID-19 infections has been advocated. Because of its wide-ranging …

This short review aimed at (i) providing an update on the health benefits associated with
melatonin supplementation, while (ii) considering future potential research directions …

Increased evidence implies that melatonin may be a promising molecule for combating
COVID-19 due to its potent antioxidative, anti-inflammatory and immunoregulatory …

Numerous pharmaceutical drugs have been repurposed for use as treatments for COVID-19
disease. These drugs have not consistently demonstrated high efficacy in preventing or …

Melatonin is registered to treat circadian rhythm sleep–wake disorders and insomnia in
patients aged 55 years and over. The essential role of the circadian sleep rhythm in the …

This article summarizes the likely benefits of melatonin in the attenuation of COVID-19
based on its putative pathogenesis. The recent outbreak of COVID-19 has become a …

Coronaviruses (CoVs) are RNA viruses that cause infections of the respiratory,
gastrointestinal, and central nervous systems, among others. The pathological symptoms of …

The current COVID-19 pandemic is one of the most devastating events in recent history. The
virus causes relatively minor damage to young, healthy populations, imposing life …

An article by Zhang et al.[1] published in the March issue of Life Sciences suggested
melatonin as a potential adjuvant treatment for COVID-19. Besides the antioxidative and …